Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 184

1.

Platelet-activating factor receptor plays a role in lung injury and death caused by Influenza A in mice.

Garcia CC, Russo RC, Guabiraba R, Fagundes CT, Polidoro RB, Tavares LP, Salgado AP, Cassali GD, Sousa LP, Machado AV, Teixeira MM.

PLoS Pathog. 2010 Nov 4;6(11):e1001171. doi: 10.1371/journal.ppat.1001171.

2.
3.

Essential role of platelet-activating factor receptor in the pathogenesis of Dengue virus infection.

Souza DG, Fagundes CT, Sousa LP, Amaral FA, Souza RS, Souza AL, Kroon EG, Sachs D, Cunha FQ, Bukin E, Atrasheuskaya A, Ignatyev G, Teixeira MM.

Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):14138-43. doi: 10.1073/pnas.0906467106. Epub 2009 Jul 30.

4.

Expression and DNA microarray analysis of a platelet activating factor-related molecule in severe pneumonia in mice due to influenza virus and bacterial co-infection.

Seki M, Kosai K, Hara A, Imamura Y, Nakamura S, Kurihara S, Izumikawa K, Kakeya H, Yamamoto Y, Yanagihara K, Miyazaki Y, Mukae H, Tashiro T, Kohno S.

Jpn J Infect Dis. 2009 Jan;62(1):6-10.

5.

Complement C5 activation during influenza A infection in mice contributes to neutrophil recruitment and lung injury.

Garcia CC, Weston-Davies W, Russo RC, Tavares LP, Rachid MA, Alves-Filho JC, Machado AV, Ryffel B, Nunn MA, Teixeira MM.

PLoS One. 2013 May 16;8(5):e64443. doi: 10.1371/journal.pone.0064443. Print 2013.

6.

Platelet Activating Factor (PAF) Receptor Deletion or Antagonism Attenuates Severe HSV-1 Meningoencephalitis.

Vilela MC, Lima GK, Rodrigues DH, Lacerda-Queiroz N, Pedroso VS, de Miranda AS, Rachid MA, Kroon EG, Campos MA, Teixeira MM, Teixeira AL.

J Neuroimmune Pharmacol. 2016 Dec;11(4):613-621. Epub 2016 May 19.

PMID:
27193134
7.

Platelet-activating factor receptor is essential for the development of experimental cerebral malaria.

Lacerda-Queiroz N, Rodrigues DH, Vilela MC, Rachid MA, Soriani FM, Sousa LP, Campos RD, Quesniaux VF, Teixeira MM, Teixeira AL.

Am J Pathol. 2012 Jan;180(1):246-55. doi: 10.1016/j.ajpath.2011.09.038. Epub 2011 Nov 8.

PMID:
22079430
8.
9.

The platelet activating factor receptor is not required for exacerbation of bacterial pneumonia following influenza.

McCullers JA, Iverson AR, McKeon R, Murray PJ.

Scand J Infect Dis. 2008;40(1):11-7. Epub 2007 Jun 21.

10.

The role of platelet-activating factor receptor (PAFR) in lung pathology during experimental malaria.

Lacerda-Queiroz N, Rachid MA, Teixeira MM, Teixeira AL.

Int J Parasitol. 2013 Jan;43(1):11-5. doi: 10.1016/j.ijpara.2012.11.008. Epub 2012 Dec 20.

PMID:
23260771
11.

Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice.

Rijneveld AW, Weijer S, Florquin S, Speelman P, Shimizu T, Ishii S, van der Poll T.

J Infect Dis. 2004 Feb 15;189(4):711-6. Epub 2004 Jan 30.

PMID:
14767826
12.

Platelet activating factor receptors drive CXC chemokine production, neutrophil influx and edema formation in the lungs of mice injected with Tityus serrulatus venom.

Coelho FM, Pessini AC, Coelho AM, Pinho VS, Souza DG, Arantes EC, Teixeira MM, Teixeira AL.

Toxicon. 2007 Sep 1;50(3):420-7. Epub 2007 Apr 25.

PMID:
17532358
13.

Platelet-activating factor receptor plays a role in the pathogenesis of graft-versus-host disease by regulating leukocyte recruitment, tissue injury, and lethality.

Castor MG, Rezende BM, Resende CB, Bernardes PT, Cisalpino D, Vieira AT, Souza DG, Silva TA, Teixeira MM, Pinho V.

J Leukoc Biol. 2012 Apr;91(4):629-39. doi: 10.1189/jlb.1111561. Epub 2012 Feb 1.

PMID:
22301794
14.

Attenuation of folic acid-induced renal inflammatory injury in platelet-activating factor receptor-deficient mice.

Doi K, Okamoto K, Negishi K, Suzuki Y, Nakao A, Fujita T, Toda A, Yokomizo T, Kita Y, Kihara Y, Ishii S, Shimizu T, Noiri E.

Am J Pathol. 2006 May;168(5):1413-24.

15.

Involvement of the platelet-activating factor receptor in host defense against Streptococcus pneumoniae during postinfluenza pneumonia.

van der Sluijs KF, van Elden LJ, Nijhuis M, Schuurman R, Florquin S, Shimizu T, Ishii S, Jansen HM, Lutter R, van der Poll T.

Am J Physiol Lung Cell Mol Physiol. 2006 Jan;290(1):L194-9. Epub 2005 Aug 12.

16.

The role of PAF/PAFR signaling in zymosan-induced articular inflammatory hyperalgesia.

Guerrero AT, Zarpelon AC, Vieira SM, Pinto LG, Ferreira SH, Cunha FQ, Verri WA Jr, Cunha TM.

Naunyn Schmiedebergs Arch Pharmacol. 2013 Jan;386(1):51-9. doi: 10.1007/s00210-012-0813-4. Epub 2012 Nov 28. Erratum in: Naunyn Schmiedebergs Arch Pharmacol. 2013 Apr;386(4):351. Zaperlon, Ana C [corrected to Zarpelon, Ana C].

PMID:
23187752
17.

MyD88 signaling is indispensable for primary influenza A virus infection but dispensable for secondary infection.

Seo SU, Kwon HJ, Song JH, Byun YH, Seong BL, Kawai T, Akira S, Kweon MN.

J Virol. 2010 Dec;84(24):12713-22. doi: 10.1128/JVI.01675-10. Epub 2010 Oct 13.

18.

Dual phase regulation of experimental allergic encephalomyelitis by platelet-activating factor.

Kihara Y, Ishii S, Kita Y, Toda A, Shimada A, Shimizu T.

J Exp Med. 2005 Sep 19;202(6):853-63.

19.

Role of the platelet-activating factor (PAF) receptor during pulmonary infection with gram negative bacteria.

Soares AC, Pinho VS, Souza DG, Shimizu T, Ishii S, Nicoli JR, Teixeira MM.

Br J Pharmacol. 2002 Nov;137(5):621-8.

20.

Absence of PAF receptor alters cellular infiltrate but not rolling and adhesion of leukocytes in experimental autoimmune encephalomyelitis.

Rodrigues DH, Lacerda-Queiroz N, de Miranda AS, Fagundes CT, Campos RD, Arantes RE, Vilela Mde C, Rachid MA, Teixeira MM, Teixeira AL.

Brain Res. 2011 Apr 18;1385:298-306. doi: 10.1016/j.brainres.2011.02.036. Epub 2011 Feb 19.

Supplemental Content

Support Center